u/CoolioBeansTTV · 182d ago2 prior · awaiting results
3 stocks under 9x forward P/E that institutions are quietly loading up on
Viatris trades at 5.5x forward P/E after restructuring into a specialty pharma and high-barrier generics player. MR-141 for presbyopia (FDA decision October) targets 90% of US adults over 45 with massive TAM, while aggressive hiring signals confidence in growth execution.